GLAXF - GlaxoSmithKline plc
Other OTC - Other OTC Delayed price. Currency in USD
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 119.55B |
| Enterprise value 3 | N/A |
| Trailing P/E | 47.60 |
| Forward P/E 1 | 0.19 |
| PEG ratio (5-yr expected) 1 | 4.35 |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 19.63 |
| Enterprise value/revenue 3 | N/A |
| Enterprise value/EBITDA 6 | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.37 |
| 52-week change 3 | 24.92% |
| S&P500 52-week change 3 | 25.78% |
| 52-week high 3 | 24.20 |
| 52-week low 3 | 18.90 |
| 50-day moving average 3 | 23.28 |
| 200-day moving average 3 | 21.59 |
Share statistics
| Avg vol (3-month) 3 | 3.94k |
| Avg vol (10-day) 3 | 4.8k |
| Shares outstanding 5 | 4.99B |
| Float | 4.9B |
| % held by insiders 1 | N/A |
| % held by institutions 1 | N/A |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 1.18 |
| Forward annual dividend yield 4 | 5.01% |
| Trailing annual dividend rate 3 | 1.06 |
| Trailing annual dividend yield 3 | 4.48% |
| 5-year average dividend yield 4 | 5.36 |
| Payout ratio 4 | 87.62% |
| Dividend date 3 | 09 Apr 2014 |
| Ex-dividend date 4 | 19 Feb 2020 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 30 Dec 2018 |
| Most-recent quarter (mrq) | 29 Sep 2019 |
Profitability
| Profit margin | 13.80% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | 7.04% |
| Return on equity (ttm) | 46.38% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | 16.00% |
| Gross profit (ttm) | 21.11B |
| EBITDA | N/A |
| Net income avi to common (ttm) | N/A |
| Diluted EPS (ttm) | 0.50 |
| Quarterly earnings growth (yoy) | 9.40% |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | 182.99 |
| Current ratio (mrq) | 0.82 |
| Book value per share (mrq) | 1.20 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |